Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies

Fast Scan Cyclic Voltammetry (FSCV) has been used for decades as a neurochemical tool for in vivo detection of phasic changes in electroactive neurotransmitters in animal models. Recently, multiple research groups have initiated human neurochemical studies using FSCV or demonstrated interest in brin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Suelen Lucio Boschen, James Trevathan, Seth A. Hara, Anders Asp, J. Luis Lujan
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/8b25810dbce24dfcb0e2123d0a2ef390
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8b25810dbce24dfcb0e2123d0a2ef390
record_format dspace
spelling oai:doaj.org-article:8b25810dbce24dfcb0e2123d0a2ef3902021-11-12T06:59:05ZDefining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies1662-453X10.3389/fnins.2021.728092https://doaj.org/article/8b25810dbce24dfcb0e2123d0a2ef3902021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnins.2021.728092/fullhttps://doaj.org/toc/1662-453XFast Scan Cyclic Voltammetry (FSCV) has been used for decades as a neurochemical tool for in vivo detection of phasic changes in electroactive neurotransmitters in animal models. Recently, multiple research groups have initiated human neurochemical studies using FSCV or demonstrated interest in bringing FSCV into clinical use. However, there remain technical challenges that limit clinical implementation of FSCV by creating barriers to appropriate scientific rigor and patient safety. In order to progress with clinical FSCV, these limitations must be first addressed through (1) appropriate pre-clinical studies to ensure accurate measurement of neurotransmitters and (2) the application of a risk management framework to assess patient safety. The intent of this work is to bring awareness of the current issues associated with FSCV to the scientific, engineering, and clinical communities and encourage them to seek solutions or alternatives that ensure data accuracy, rigor and reproducibility, and patient safety.Suelen Lucio BoschenJames TrevathanSeth A. HaraAnders AspAnders AspJ. Luis LujanJ. Luis LujanFrontiers Media S.A.articleclinical neurochemistrydeep brain stimulationfast scan cyclic voltammetryintraoperativeneurochemical signalingneurophysiologyNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Neuroscience, Vol 15 (2021)
institution DOAJ
collection DOAJ
language EN
topic clinical neurochemistry
deep brain stimulation
fast scan cyclic voltammetry
intraoperative
neurochemical signaling
neurophysiology
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle clinical neurochemistry
deep brain stimulation
fast scan cyclic voltammetry
intraoperative
neurochemical signaling
neurophysiology
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Suelen Lucio Boschen
James Trevathan
Seth A. Hara
Anders Asp
Anders Asp
J. Luis Lujan
J. Luis Lujan
Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies
description Fast Scan Cyclic Voltammetry (FSCV) has been used for decades as a neurochemical tool for in vivo detection of phasic changes in electroactive neurotransmitters in animal models. Recently, multiple research groups have initiated human neurochemical studies using FSCV or demonstrated interest in bringing FSCV into clinical use. However, there remain technical challenges that limit clinical implementation of FSCV by creating barriers to appropriate scientific rigor and patient safety. In order to progress with clinical FSCV, these limitations must be first addressed through (1) appropriate pre-clinical studies to ensure accurate measurement of neurotransmitters and (2) the application of a risk management framework to assess patient safety. The intent of this work is to bring awareness of the current issues associated with FSCV to the scientific, engineering, and clinical communities and encourage them to seek solutions or alternatives that ensure data accuracy, rigor and reproducibility, and patient safety.
format article
author Suelen Lucio Boschen
James Trevathan
Seth A. Hara
Anders Asp
Anders Asp
J. Luis Lujan
J. Luis Lujan
author_facet Suelen Lucio Boschen
James Trevathan
Seth A. Hara
Anders Asp
Anders Asp
J. Luis Lujan
J. Luis Lujan
author_sort Suelen Lucio Boschen
title Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies
title_short Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies
title_full Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies
title_fullStr Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies
title_full_unstemmed Defining a Path Toward the Use of Fast-Scan Cyclic Voltammetry in Human Studies
title_sort defining a path toward the use of fast-scan cyclic voltammetry in human studies
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/8b25810dbce24dfcb0e2123d0a2ef390
work_keys_str_mv AT suelenlucioboschen definingapathtowardtheuseoffastscancyclicvoltammetryinhumanstudies
AT jamestrevathan definingapathtowardtheuseoffastscancyclicvoltammetryinhumanstudies
AT sethahara definingapathtowardtheuseoffastscancyclicvoltammetryinhumanstudies
AT andersasp definingapathtowardtheuseoffastscancyclicvoltammetryinhumanstudies
AT andersasp definingapathtowardtheuseoffastscancyclicvoltammetryinhumanstudies
AT jluislujan definingapathtowardtheuseoffastscancyclicvoltammetryinhumanstudies
AT jluislujan definingapathtowardtheuseoffastscancyclicvoltammetryinhumanstudies
_version_ 1718431120511467520